We have demonstrated, for the first time, that the downstream KP enzymes KMO and KYNU are hyperactive in more aggressive BrCa subtypes, leading to enhanced production of the immunosuppressive metabolites AA and 3HAA. This evidence concerns the gene KMO and invasive breast carcinoma.